tiprankstipranks
Accelerate Diagnostics’ Shareholder Decisions at Annual Meeting
Company Announcements

Accelerate Diagnostics’ Shareholder Decisions at Annual Meeting

Don't Miss our Black Friday Offers:

Accelerate Diagnostics (AXDX) has issued an announcement.

During the 2024 Annual Meeting, shareholders of the Company made key decisions: they elected nine directors to serve until the next annual meeting, ratified Ernst & Young LLP as their independent accounting firm for the year, and approved an amendment to increase the number of shares available for the 2022 Incentive Plan. The detailed voting results reflected strong support for the elected directors and the ratification of the accounting firm, with a more divided outcome on the plan amendment.

Learn more about AXDX stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAccelerate Diagnostics Reports Key Advances Amid Financial Challenges
Jason CarrAXDX Upcoming Earnings Report: What to Expect?
TheFlyAccelerate Diagnostics announces FDA clearance of Accelerate Arc system
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App